ResearcherWestlake UniversityActive in the last 2 years

Yan Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9311-6077; OpenAlex author ID A5028312744. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial cells changes. Co-author DOI 10.1016/j.jep.2024.118711 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jianfeng Yang · 1 shared paper, 2025 · strength 0.28
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711 ↗
Hangbin Jin · 1 shared paper, 2025 · strength 0.28
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711 ↗
Yu Wang · 1 shared paper, 2025 · strength 0.28
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711 ↗
Xiaofeng Zhang · 1 shared paper, 2025 · strength 0.28
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.